http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3165729-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3b4d4b73fec00610e73dcd843f0b1c7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00708
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2562-0247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2217-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2218-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2562-0257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2562-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-167
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1206
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12
filingDate 2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c202ba361668ee538ee6d6025187859a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17145421fe7bb74245ca5b50db5802c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c93abfc0c5e4f5225903a6f1767a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed31d8da997cb6fa9143198b73b7267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f4b05c90c3b400de9be5a8bf69b5a12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_632290051a2f59bbbcd1e72cfd7061df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8844e042de8c761251998cb7713be9e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0f66e8a72b26c4c2cb8f5b4cd496c30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd0826f34ea4deb01bd57f35f09ca54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fdee34e973c2e408e234d89e8e45473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3fc6e1864840e9248e9966553f637ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c6ac0ff18f138c0fde85d0db094ce7
publicationDate 2021-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3165729-A1
titleOfInvention Treatment of cardiac tissue with pulsed electric fields
abstract Devices, systems and methods are provided for treating conditions of the heart, particularly the occurrence of arrhythmias. The devices, systems and methods deliver therapeutic energy to portions the heart to provide tissue modification, such as to the entrances to the pulmonary veins in the treatment of atrial fibrillation. Generally, the tissue modification systems include a specialized catheter, a high voltage waveform generator and at least one distinct energy delivery algorithm. Other embodiments include conventional ablation catheters and system components to enable use with a high voltage waveform generator. Example catheter designs include a variety of delivery types including focal delivery, "one-shot" delivery and various possible combinations. In some embodiments, energy is delivered in a monopolar fashion. However, it may be appreciated that a variety of other embodiments are also provided.
priorityDate 2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44073

Total number of triples: 63.